Target product profile for a test for the early assessment of treatment efficacy in Chagas disease patients: An expert consensus
| Autor(a) principal: | |
|---|---|
| Data de Publicação: | 2020 |
| Outros Autores: | , , , , , , , , , , , , , , , , , , , , , , , |
| Tipo de documento: | Artigo |
| Idioma: | eng |
| Título da fonte: | Repositório Institucional da FIOCRUZ (ARCA) |
| Texto Completo: | https://www.arca.fiocruz.br/handle/icict/41546 |
Resumo: | 2020-11-01 |
| id |
CRUZ_d046f5da22c5a034d04b906b92a66880 |
|---|---|
| oai_identifier_str |
oai:www.arca.fiocruz.br:icict/41546 |
| network_acronym_str |
CRUZ |
| network_name_str |
Repositório Institucional da FIOCRUZ (ARCA) |
| repository_id_str |
2135 |
| spelling |
Alonso-Padilla, JulioAbril, MarceloAlarcón de Noya, BelkisyoléAlmeida, Igor C.Angheben, AndreaAraujo Jorge, TaniaChatelain, EricEsteva, MonicaGascón, JoaquimGrijalva, Mario J.Guhl, FelipeHasslocher-Moreno, Alejandro MarcelLópez, Manuel CarlosLuquetti, AlejandroNoya, OscarPinazo, María JesúsRamsey, Janine M.Ribeiro, IsabelaRuiz, Andres MarianoSchijman, Alejandro G.Sosa-Estani, SergioThomas, M. C.Torrico, FaustinoZrein, MaanPicado, Albert2020-06-04T22:28:15Z2020-06-04T22:28:15Z2020ALONSO-PADILLA, Julio et al. Target Product Profile for a Test for the Early Assessment of Treatment Efficacy in Chagas Disease Patients: An Expert Consensus. PLoS Neglected Tropical Diseases, v. 14, n. 4, p. 1-10, 2020.1935-2727https://www.arca.fiocruz.br/handle/icict/4154610.1371/journal.pntd.0008035engPublic Library of ScienceTarget product profile for a test for the early assessment of treatment efficacy in Chagas disease patients: An expert consensusinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article2020-11-01Barcelona Institute for Global Health. Hospital Clínic-University of Barcelona. Barcelona, Spain.Fundación Mundo Sano. Buenos Aires, Argentina.Universidad Central de Venezuela. Instituto de Medicina Tropical. Caracas, Venezuela.University of Texas at El Paso. Department of Biological Sciences. Border Biomedical Research Center. El Paso, Texas, United States of America.IRCCS Sacro Cuore Don Calabria Hospital. Department of Infectious-Tropical Diseases and Microbiology. Negrar di Valpolicella, Verona, Italy.Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Rio de Janeiro, RJ, Brasil.Drugs for Neglected Diseases Initiative. Geneva, Switzerland.Ministerio de Salud. Instituto Nacional de Parasitología "Dr. Mario Fatala Chaben". ANLIS "Dr. Carlos G. Malbrán". Buenos Aires, Argentina.Barcelona Institute for Global Health. Hospital Clínic-University of Barcelona. Barcelona, Spain.Pontificia Universidad Católica del Ecuador. Centro de Investigación para la Salud en América Latina. Quito, Ecuador / Ohio University. Biomedical Sciences Department. Infectious and Tropical Disease Institute. Athens, Ohio, United States of America.Universidad de los Andes. Centro de Investigaciones en Microbiología y Parasitología Tropical. Bogotá, Colombia.Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil.Consejo Superior de Investigaciones Científicas. Instituto de Parasitología y Biomedicina López Neyra. Granada, Spain.Universidade Federal de Goiás. Hospital das Clínicas. Goiania, Brasil.Universidad Central de Venezuela. Instituto de Medicina Tropical. Caracas, Venezuela.Barcelona Institute for Global Health. Hospital Clínic-University of Barcelona. Barcelona, Spain.Instituto Nacional de Salud Pública/CRISP. Tapachula, Chiapas, Mexico.Drugs for Neglected Diseases Initiative. Geneva, Switzerland.Ministerio de Salud. Instituto Nacional de Parasitología "Dr. Mario Fatala Chaben". ANLIS "Dr. Carlos G. Malbrán". Buenos Aires, Argentina.Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Investigaciones en Ingeniería Genética y Biología Molecular. Buenos Aires, Argentina.Drugs for Neglected Disease initiative Latin America. Rio de Janeiro, RJ, Brasil / CONICET. Epidemiology and Public Health Research Center. Buenos Aires, Argentina.Consejo Superior de Investigaciones Científicas. Instituto de Parasitología y Biomedicina López Neyra. Granada, Spain.Fundación CEADES / Universidad Mayor de San Simón. Cochabamba, Bolivia.Infynity Biomarkers. Lyon, France.Foundation for Innovative Diagnostics. Geneva, Switzerland.Six to 7 million people are estimated to be infected by Trypanosoma cruzi, the parasite causing Chagas disease. However, only a small fraction of patients are properly diagnosed and treated. Benznidazole (BNZ) and nifurtimox (NFX) are the first-line antiparasitic treatments currently available, both with long administration regimens (60 days) that can produce adverse side effects. Despite the fact they are not 100% effective in patients with chronic disease, they are the only drugs currently registered, and the benefits of their administration have been confirmed in several clinical studies. Currently, clinical trials with new compounds, using alternative regimens that aim to maintain efficacy whilst reducing toxicity, are ongoing and could lead to new therapeutic opportunities and/or policy change. In any case, the absence of a test for the early assessment of treatment efficacy, often called a test of cure (ToC), is a major obstacle to Chagas disease control. Accurately monitoring treatment response would undoubtedly improve patient management and support the conduct of clinical trials. Although treatment efficacy and treatment response may be conceptually different, we are using these terms synonymously for the purpose of the current target product profile (TPP).Chagas diseaseParasitic diseasesTrypanosoma cruziDiagnostic medicineBiomarkersDrug screeningSerologyTreatment guidelinesinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txtlicense.txttext/plain; charset=utf-83099https://www.arca.fiocruz.br/bitstream/icict/41546/1/license.txt586c046dcfeef936e32f0323bb9a47c0MD51ORIGINALTarget_Alejandro_Hasslocher-Moreno_etal_INI_2020.pdfTarget_Alejandro_Hasslocher-Moreno_etal_INI_2020.pdfapplication/pdf453951https://www.arca.fiocruz.br/bitstream/icict/41546/2/Target_Alejandro_Hasslocher-Moreno_etal_INI_2020.pdf5de1439d33071488cc93ff2a7f9007ceMD52TEXTTarget_Alejandro_Hasslocher-Moreno_etal_INI_2020.pdf.txtTarget_Alejandro_Hasslocher-Moreno_etal_INI_2020.pdf.txtExtracted texttext/plain43268https://www.arca.fiocruz.br/bitstream/icict/41546/3/Target_Alejandro_Hasslocher-Moreno_etal_INI_2020.pdf.txtb22c76617f63d236120b17fa7f9323d1MD53icict/415462021-03-24 16:32:38.27oai:www.arca.fiocruz.br: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ório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352021-03-24T19:32:38Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false |
| dc.title.pt_BR.fl_str_mv |
Target product profile for a test for the early assessment of treatment efficacy in Chagas disease patients: An expert consensus |
| title |
Target product profile for a test for the early assessment of treatment efficacy in Chagas disease patients: An expert consensus |
| spellingShingle |
Target product profile for a test for the early assessment of treatment efficacy in Chagas disease patients: An expert consensus Alonso-Padilla, Julio Chagas disease Parasitic diseases Trypanosoma cruzi Diagnostic medicine Biomarkers Drug screening Serology Treatment guidelines |
| title_short |
Target product profile for a test for the early assessment of treatment efficacy in Chagas disease patients: An expert consensus |
| title_full |
Target product profile for a test for the early assessment of treatment efficacy in Chagas disease patients: An expert consensus |
| title_fullStr |
Target product profile for a test for the early assessment of treatment efficacy in Chagas disease patients: An expert consensus |
| title_full_unstemmed |
Target product profile for a test for the early assessment of treatment efficacy in Chagas disease patients: An expert consensus |
| title_sort |
Target product profile for a test for the early assessment of treatment efficacy in Chagas disease patients: An expert consensus |
| author |
Alonso-Padilla, Julio |
| author_facet |
Alonso-Padilla, Julio Abril, Marcelo Alarcón de Noya, Belkisyolé Almeida, Igor C. Angheben, Andrea Araujo Jorge, Tania Chatelain, Eric Esteva, Monica Gascón, Joaquim Grijalva, Mario J. Guhl, Felipe Hasslocher-Moreno, Alejandro Marcel López, Manuel Carlos Luquetti, Alejandro Noya, Oscar Pinazo, María Jesús Ramsey, Janine M. Ribeiro, Isabela Ruiz, Andres Mariano Schijman, Alejandro G. Sosa-Estani, Sergio Thomas, M. C. Torrico, Faustino Zrein, Maan Picado, Albert |
| author_role |
author |
| author2 |
Abril, Marcelo Alarcón de Noya, Belkisyolé Almeida, Igor C. Angheben, Andrea Araujo Jorge, Tania Chatelain, Eric Esteva, Monica Gascón, Joaquim Grijalva, Mario J. Guhl, Felipe Hasslocher-Moreno, Alejandro Marcel López, Manuel Carlos Luquetti, Alejandro Noya, Oscar Pinazo, María Jesús Ramsey, Janine M. Ribeiro, Isabela Ruiz, Andres Mariano Schijman, Alejandro G. Sosa-Estani, Sergio Thomas, M. C. Torrico, Faustino Zrein, Maan Picado, Albert |
| author2_role |
author author author author author author author author author author author author author author author author author author author author author author author author |
| dc.contributor.author.fl_str_mv |
Alonso-Padilla, Julio Abril, Marcelo Alarcón de Noya, Belkisyolé Almeida, Igor C. Angheben, Andrea Araujo Jorge, Tania Chatelain, Eric Esteva, Monica Gascón, Joaquim Grijalva, Mario J. Guhl, Felipe Hasslocher-Moreno, Alejandro Marcel López, Manuel Carlos Luquetti, Alejandro Noya, Oscar Pinazo, María Jesús Ramsey, Janine M. Ribeiro, Isabela Ruiz, Andres Mariano Schijman, Alejandro G. Sosa-Estani, Sergio Thomas, M. C. Torrico, Faustino Zrein, Maan Picado, Albert |
| dc.subject.en.pt_BR.fl_str_mv |
Chagas disease Parasitic diseases Trypanosoma cruzi Diagnostic medicine Biomarkers Drug screening Serology Treatment guidelines |
| topic |
Chagas disease Parasitic diseases Trypanosoma cruzi Diagnostic medicine Biomarkers Drug screening Serology Treatment guidelines |
| description |
2020-11-01 |
| publishDate |
2020 |
| dc.date.accessioned.fl_str_mv |
2020-06-04T22:28:15Z |
| dc.date.available.fl_str_mv |
2020-06-04T22:28:15Z |
| dc.date.issued.fl_str_mv |
2020 |
| dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
| dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.citation.fl_str_mv |
ALONSO-PADILLA, Julio et al. Target Product Profile for a Test for the Early Assessment of Treatment Efficacy in Chagas Disease Patients: An Expert Consensus. PLoS Neglected Tropical Diseases, v. 14, n. 4, p. 1-10, 2020. |
| dc.identifier.uri.fl_str_mv |
https://www.arca.fiocruz.br/handle/icict/41546 |
| dc.identifier.issn.pt_BR.fl_str_mv |
1935-2727 |
| dc.identifier.doi.none.fl_str_mv |
10.1371/journal.pntd.0008035 |
| identifier_str_mv |
ALONSO-PADILLA, Julio et al. Target Product Profile for a Test for the Early Assessment of Treatment Efficacy in Chagas Disease Patients: An Expert Consensus. PLoS Neglected Tropical Diseases, v. 14, n. 4, p. 1-10, 2020. 1935-2727 10.1371/journal.pntd.0008035 |
| url |
https://www.arca.fiocruz.br/handle/icict/41546 |
| dc.language.iso.fl_str_mv |
eng |
| language |
eng |
| dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
| eu_rights_str_mv |
openAccess |
| dc.publisher.none.fl_str_mv |
Public Library of Science |
| publisher.none.fl_str_mv |
Public Library of Science |
| dc.source.none.fl_str_mv |
reponame:Repositório Institucional da FIOCRUZ (ARCA) instname:Fundação Oswaldo Cruz (FIOCRUZ) instacron:FIOCRUZ |
| instname_str |
Fundação Oswaldo Cruz (FIOCRUZ) |
| instacron_str |
FIOCRUZ |
| institution |
FIOCRUZ |
| reponame_str |
Repositório Institucional da FIOCRUZ (ARCA) |
| collection |
Repositório Institucional da FIOCRUZ (ARCA) |
| bitstream.url.fl_str_mv |
https://www.arca.fiocruz.br/bitstream/icict/41546/1/license.txt https://www.arca.fiocruz.br/bitstream/icict/41546/2/Target_Alejandro_Hasslocher-Moreno_etal_INI_2020.pdf https://www.arca.fiocruz.br/bitstream/icict/41546/3/Target_Alejandro_Hasslocher-Moreno_etal_INI_2020.pdf.txt |
| bitstream.checksum.fl_str_mv |
586c046dcfeef936e32f0323bb9a47c0 5de1439d33071488cc93ff2a7f9007ce b22c76617f63d236120b17fa7f9323d1 |
| bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 |
| repository.name.fl_str_mv |
Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ) |
| repository.mail.fl_str_mv |
repositorio.arca@fiocruz.br |
| _version_ |
1798325028663590912 |